Literature DB >> 2967546

Hypertensive concentric left ventricular hypertrophy: when is ventricular ectopic activity increased?

C J Lavie1, B D Nunez, G E Garavaglia, F H Messerli.   

Abstract

The Framingham Study has indicated that patients with left ventricular hypertrophy (LVH) have a greater risk of cardiovascular complications and sudden death than subjects with a normal heart. We have previously demonstrated that ventricular ectopy was more prevalent and complex in hypertensive patients with LVH by electrocardiographic (ECG) criteria than in those without ECG evidence of LVH. The present study was designed to detect and quantify ventricular dysrhythmias in hypertensive patients with early concentric LVH by echocardiography but without LVH by ECG criteria. Continuous ambulatory ECG tracings were recorded for 24 hours in 94 patients with essential hypertension: 37 without LVH, 26 with concentric LVH by echocardiographic but not ECG criteria, and 31 with LVH on both echocardiography and ECG. Patients with LVH by ECG criteria had significantly more premature ventricular contractions (P less than .001) and more complex (higher Lown's class) ventricular ectopy (P less than .001) than hypertensives without LVH or with LVH only by echocardiographic criteria. Prevalence and complexity of ventricular ectopic activity, however, was not affected by mild to moderate concentric cardiac hypertrophy detected echocardiographically. We conclude that unlike LVH shown by ECG, early hypertensive concentric LVH detected echocardiographically is not associated with increased electrical irritability of the myocardium.

Entities:  

Mesh:

Year:  1988        PMID: 2967546     DOI: 10.1097/00007611-198806000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

Review 1.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

2.  Exercise and the heart: risks, benefits, and recommendations for providing exercise prescriptions.

Authors:  C J Lavie; R V Milani; P Marks; H de Gruiter
Journal:  Ochsner J       Date:  2001-10

3.  Impact of left ventricular geometry on prognosis-a review of ochsner studies.

Authors:  Carl J Lavie; Richard V Milani; Sangeeta B Shah; Yvonne E Gilliland; Jose A Bernal; Homeyar Dinshaw; Hector O Ventura
Journal:  Ochsner J       Date:  2008

Review 4.  Cardiac rehabilitation, exercise training, and preventive cardiology research at Ochsner Heart and Vascular Institute.

Authors:  C J Lavie; R V Milani; H O Ventura; F H Messerli; J P Murgo
Journal:  Tex Heart Inst J       Date:  1995

Review 5.  Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?

Authors:  F H Messerli; F Soria
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 6.  Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.

Authors:  F H Messerli; F Soria
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 7.  Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?

Authors:  R Nadarajah; P A Patel; M H Tayebjee
Journal:  J Hum Hypertens       Date:  2021-03-05       Impact factor: 3.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.